Literature DB >> 27380207

Immunologic Abnormalities, Treatments, and Recurrent Pregnancy Loss: What Is Real and What Is Not?

Nathalie F Wang1, Astrid M Kolte, Elisabeth C Larsen, Henriette S Nielsen, Ole B Christiansen.   

Abstract

Recurrent pregnancy loss, depending on the definition, affects 1% to 3% of women aiming to have a child. Little is known about the direct causes of recurrent pregnancy loss, and the condition is considered to have a multifactorial and complex pathogenesis. The aim of this review was to summarize the evaluation and the management of the condition with specific emphasis on immunologic biomarkers identified as risk factors as well as current immunologic treatment options. The review also highlights and discusses areas in need of further research.

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27380207     DOI： 10.1097/GRF.0000000000000215

Source DB:  PubMed          Journal:  Clin Obstet Gynecol        ISSN： 0009-9201            Impact factor:   2.190


  8 in total

1.  Glucocorticoids Improve the Pregnancy Rate and Outcome in Women With Unexplained Positive Autoantibodies: A Systematic Review and Meta-Analysis.

Authors:  Ting Li; Yilin Yuan; Huixin Liu; Qun Lu; Rong Mu
Journal:  Front Med (Lausanne)       Date:  2022-05-11

2.  Plasma level of mannose-binding lectin is associated with the risk of recurrent pregnancy loss but not pregnancy outcome after the diagnosis.

Authors:  C Nørgaard-Pedersen; L H Rom; R Steffensen; U S Kesmodel; O B Christiansen
Journal:  Hum Reprod Open       Date:  2022-06-07

3.  Differences in the Association Between Oral Glucocorticoids and Risk of Preterm Birth by Data Source: Reconciling the Results.

Authors:  Kristin Palmsten; Gretchen Bandoli; Gabriela Vazquez-Benitez; Christina D Chambers
Journal:  Arthritis Care Res (Hoboken)       Date:  2022-05-20       Impact factor: 5.178

4.  Morphometric and Nanomechanical Features of Erythrocytes Characteristic of Early Pregnancy Loss.

Authors:  Ariana Langari; Velichka Strijkova; Regina Komsa-Penkova; Avgustina Danailova; Sashka Krumova; Stefka G Taneva; Ina Giosheva; Emil Gartchev; Kamelia Kercheva; Alexey Savov; Svetla Todinova
Journal:  Int J Mol Sci       Date:  2022-04-19       Impact factor: 6.208

5.  Detection of non-criteria autoantibodies in women without apparent causes for pregnancy loss.

Authors:  Hongyuan Zhu; Meng Wang; Ying Dong; Honghai Hu; Qiaoli Zhang; Chen Qiao; Xin Xie; Fei Fan; Jiazi Zeng; Yan Jia; Lu Chen; Jingrui Liu; Lin Li; Yanhong Zhai; Zhen Zhao; Min Shen; Zheng Cao
Journal:  J Clin Lab Anal       Date:  2019-08-11       Impact factor: 2.352

6.  The Endometrial Immune Profiling May Positively Affect the Management of Recurrent Pregnancy Loss.

Authors:  Meryam Cheloufi; Alaa Kazhalawi; Anne Pinton; Mona Rahmati; Lucie Chevrier; Laura Prat-Ellenberg; Anne-Sophie Michel; Geraldine Dray; Arsène Mekinian; Gilles Kayem; Nathalie Lédée
Journal:  Front Immunol       Date:  2021-03-24       Impact factor: 7.561

7.  Characterisation of peri-implantation endometrial Treg and identification of an altered phenotype in recurrent pregnancy loss.

Authors:  Ingrid Granne; Mengni Shen; Helena Rodriguez-Caro; Gurmeher Chadha; Elizabeth O'Donnell; Jan J Brosens; Siobhan Quenby; Tim Child; Jennifer H Southcombe
Journal:  Mucosal Immunol       Date:  2021-09-22       Impact factor: 7.313

Review 8.  Endometrial Immune Dysfunction in Recurrent Pregnancy Loss.

Authors:  Carlo Ticconi; Adalgisa Pietropolli; Nicoletta Di Simone; Emilio Piccione; Asgerally Fazleabas
Journal:  Int J Mol Sci       Date:  2019-10-26       Impact factor: 5.923
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.